Content area
Full Text
Following a diversified path leads agency to a "significant"year
A "significant" year is how The Access Group's president and CEO, Dave Gagliano, describes his agency's 2013. In an industry not known for understatement, this seems like a positively bland adjective to describe a year in which The Access Group added 34 accounts, doubled its bottom line, and experienced a large bounce in management consulting revenue. The agency added new clients Anacor Pharmaceuticals, Astellas Pharma US, BioMarin Pharmaceutical, Celgene, Millennium Pharmaceuticals, Patheon, Amgen (including Onyx), and Salix Pharmaceuticals; earned organic growth from standing clients Merck, Bristol-Myers Squibb, AstraZeneca, and Vertex; and saw its promotional subdivision Med Access launch ReGenica Day and Overnight Repair, Hydrate Luxe, Gentle Rejuvenation, and Obagi360 for Obagi Medical Products. Significant, indeed.
Playing a, well, significant role in all this was The Access Group's management consulting division, Promidian. Demand for Promidian's services was so strong that the agency added five new staff members and opened an office in San Francisco. "In 2013, we experienced...